Christopher Murray
Chief Tech/Sci/R&D Officer chez BLUEPRINT MEDICINES CORPORATION
Fortune : 3 M $ au 31/03/2024
Postes actifs de Christopher Murray
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 10/10/2017 | - |
Historique de carrière de Christopher Murray
Anciens postes connus de Christopher Murray
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2013 | 01/05/2017 |
Formation de Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Christopher Murray
- Expérience
